Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Connected Government
- Consolidating Mission-critical Systems
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Data Privacy Imperative: Safeguarding Sensitive Data
- Eliminating the Pitfalls: Steps to Virtualization in Government
- Federal Executive Forum
- Federal Tech Talk
- Government Cloud Brokerage: Who, What, When, Where, Why?
- Government Mobility
- Mission-critical Apps in the Cloud
- Mobile Device Management
- The Modern Federal Threat Landscape
- The Path from Legacy Systems
- Understanding the Intersection of Customer Service and Security in the Cloud
Shows & Panels
Search Tags: FDA
The Food and Drug Administration takes too long to approve potentially life-saving treatments and devices, says the agency's former head.
Budget pressures could delay some of the General Services Administration's building projects — or scrap them altogether. Art Turowski, a senior vice president with the Government Investor Services group in Jones Lang LaSalle, joined In Depth with Francis Rose to discuss what the new spending numbers mean for the government's large-scale construction projects.
This month the National Institutes of Health created the new National Center for Advancing Translational Sciences (NCATS) to bridge the gap between scientific research and usable drugs or medical devices.
Peter Lurie, a senior advisor in the Office of the Commissioner at the FDA, told the Federal Drive with Tom Temin and Amy Morris the sooner the agency learns of an impending drug shortage the sooner it can take action.
Julian Pecquet, a staff writer for The Hill newspaper, joined the Federal Drive with Tom Temin and Amy Morris to discuss how a recent Executive Order affects the FDA's day-to-day business and more broadly how such orders affect agency operations.
President Barack Obama ordered the Food and Drug Administration on Monday to take new steps to send out early warnings about looming shortages and try to avert them.
Doctors are recommending those in the high risk groups get vaccinated next month, even though flu season doesn't usually arrive until October.
Congressional watchdog has suggestions as to how FDA can improve.
Getting to the heart (and lungs) of the matter